Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01403298 · ClinicalTrials.gov registry record · NA

Project RAP: Family-based HIV Prevention in the Juvenile Drug Court

A NA study of HIV/AIDS, sponsored by University of California, San Francisco.

Completed
Registry status
NA
Development phase
120
Enrollment target
1
Study location

NCT01403298 is a NA study of HIV/AIDS that has completed, run by University of California, San Francisco. The registered enrollment target is 120 participants, below the 33,179-participant average among 61 other HIV/AIDS trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01403298, a NA study of HIV/AIDS, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
NA
Development phase
120 participants
Enrollment target
1
Study location

Study Summary

The purpose of this project is to compare the effect of a family-based HIV prevention program to the effect of an adolescent-only health promotion program on adolescent HIV risk and marijuana use among adolescents enrolled in the Juvenile Drug Court (JDC) of the Rhode Island Family Court.

Conditions Studied

Interventions

  • BEHAVIORAL Family-Based HIV prevention
  • OTHER Adolescent Only Health Promotion

Study Locations (1)

Rhode Island

  • Rhode Island Hospital - Providence

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2009-12
Est. Completion 2013-06
Phase NA

What the Registry Record Tells You About NCT01403298

The ClinicalTrials.gov registry entry for NCT01403298 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 33,179-participant average among 61 other HIV/AIDS trials with a reported enrollment target (100% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HIV/AIDS appearing as the primary indexed condition, and to 2 interventions - of which Family-Based HIV prevention is the first listed.

NCT01403298 reports 1 study location spanning 1 distinct geographic area - top geographies include Rhode Island.

Frequently Asked Questions

What is clinical trial NCT01403298 about?

NCT01403298 is a clinical study titled "Project RAP: Family-based HIV Prevention in the Juvenile Drug Court". The purpose of this project is to compare the effect of a family-based HIV prevention program to the effect of an adolescent-only health promotion program on adolescent HIV risk and marijuana use among adolescents enrolled in the Juvenile Drug Court (JDC) of the Rhode Island Family Court.

What is the current status of trial NCT01403298?

This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2009-12. Estimated completion is 2013-06.

What conditions does trial NCT01403298 study?

This clinical trial studies the following conditions: HIV/AIDS.

What interventions are being tested in trial NCT01403298?

The interventions under investigation include: Family-Based HIV prevention (BEHAVIORAL), Adolescent Only Health Promotion (OTHER).

Who is sponsoring clinical trial NCT01403298?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01403298 being conducted?

This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV/AIDS

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.